Maurizio Casarrubea Selected Research

Maurizio Casarrubea Research Topics

4	Pain (Aches) 09/2019 - 08/2012
2	Seizures (Absence Seizure) 01/2022 - 01/2019
2	Tobacco Use Disorder (Nicotine Dependence) 04/2021 - 03/2020
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Brain Diseases (Brain Disorder) 01/2020
1	Epilepsy (Aura) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Tics (Tic) 01/2017

2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2022 - 01/2022
2	Nicotine FDA Link 04/2021 - 03/2020
2	Morphine (MS Contin)FDA LinkGeneric 09/2019 - 08/2016
1	EndocannabinoidsIBA 01/2022
1	Cannabinoid Receptor AgonistsIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	CannabinoidsIBA 01/2022
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2020
1	lorcaserinIBA 01/2020
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 08/2012
1	Diazepam (Valium)FDA LinkGeneric 08/2012

1	Analgesia 08/2016